What Would You Pay to Stay Alive?
What Next | Daily News and Analysis
00:00
From Thalidomide to Revlimid: A Patient's Journey
This chapter traces the evolution of Revlimid, a cancer treatment with roots in the controversial thalidomide drug, detailing its development from a leprosy remedy to a breakthrough for multiple myeloma. It focuses on the personal story of Beth Woolmer, whose advocacy for her husband led to the re-evaluation of thalidomide's potential, while also examining the critical issues of drug pricing and accessibility.
Transcript
Play full episode
